The American Cancer Society and Pfizer Launch Community Grants Focused on Reducing Prostate Cancer Disparities Among Black Men prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stop & Shop Kicks Off Annual ‘Help Cure Childhood Cancer’ Campaign
Stop and ShopMarch 1, 2021 GMT
QUINCY, Mass., March 01, 2021 (GLOBE NEWSWIRE) Stop & Shop today announced the start of its annual ‘Help Cure Childhood Cancer’ campaign to support Dana-Farber Cancer Institute and the Jimmy Fund in Massachusetts and MSK Kids, the Pediatrics Program at Memorial Sloan Kettering Cancer Center in New York. Since the campaign’s inception decades ago, Stop & Shop and its customers have contributed more than $100 million to these two hospitals, allowing them to make significant advancements in pediatric cancer research and care.
Ibram X. Kendi is featured speaker in forum on his experience with colon cancer and its impact on his groundbreaking work on antiracism Launch of "Gut.
Date Time
Share
Dana-Farber, Broad Institute and Count Me In receive $16 million grant to launch patient-partnered research initiatives
Funding from the National Cancer Institute will help optimize patient engagement in research while studying osteosarcoma and leiomyosarcoma
Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, and Count Me In, a non-profit research initiative that conducts patient-partnered studies of cancer, have been awarded a new $16 million grant from the National Cancer Institute, to accelerate research in two rare forms of cancer. The funding will support research projects in leiomyosarcoma and osteosarcoma, two cancers which have seen few recent therapeutic advances, while simultaneously yielding new information about the best ways to engage with patients traditionally underrepresented in cancer research. The goal of these projects is to accelerate discoveries that can drive new insights into the genomic roots of rare cancer, discover mec
Share this article
Share this article
BOSTON, Feb. 17, 2021 /PRNewswire/ The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with GBS’s transistor technology in developing a multiplexed COVID-19 biomarker diagnostic. Credit: Wyss Institute at Harvard University